Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04072159 · ClinicalTrials.gov registry record · NA

Community Pharmacists Vaccinate Against Cancer

A NA study of Human Papillomavirus Vaccines, sponsored by Arizona State University.

Completed
Registry status
NA
Development phase
33
Enrollment target
1
Study location

NCT04072159 is a NA study of Human Papillomavirus Vaccines that has completed, run by Arizona State University. The registered enrollment target is 33 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04072159, a NA study of Human Papillomavirus Vaccines, has completed, sponsored by Arizona State University.

COMPLETED
Registry status
NA
Development phase
33 participants
Enrollment target
1
Study location

Study Summary

Latino and African American populations have a higher rate of human papillomavirus (HPV) vaccine initiation; however, they have a significantly less likelihood of completing the vaccine series. Pharmacists are licensed to vaccinate against the HPV virus. However, they are less likely to administer the vaccine. Although past research has recommended incorporating pharmacists to increase adolescent vaccination, no intervention studies, to our knowledge, have tested a healthcare delivery model that incorporates pharmacists to complete the HPV vaccine series. The aims of this pilot randomized controlled trial are to 1) determine the preliminary efficacy of an intervention to increase HPV vaccine series completion with the community pharmacist vs. with the primary care provider among racially/ethnically diverse participants, and 2) assess perceived intervention feasibility and acceptability of the intervention among intervention participants and primary care clinic staff.

Interventions

  • BEHAVIORAL Community Pharmacists Vaccinating Against Cancer

Study Locations (1)

Arizona

  • Adelante Healthcare Mesa - Mesa

Trial Details

FieldValue
Enrollment Target 33 participants
Start Date 2019-04-01
Est. Completion 2021-02-01
Phase NA

Sponsor

Arizona State University

187 total trials

What the Registry Record Tells You About NCT04072159

The ClinicalTrials.gov registry entry for NCT04072159 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Arizona State University, which has 187 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Human Papillomavirus Vaccines appearing as the primary indexed condition, and to 1 intervention - of which Community Pharmacists Vaccinating Against Cancer is the first listed.

NCT04072159 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.

Frequently Asked Questions

What is clinical trial NCT04072159 about?

NCT04072159 is a clinical study titled "Community Pharmacists Vaccinate Against Cancer". Latino and African American populations have a higher rate of human papillomavirus (HPV) vaccine initiation; however, they have a significantly less likelihood of completing the vaccine series. Pharmacists are licensed to vaccinate against the HPV virus. However, they are less likely to administer t...

What is the current status of trial NCT04072159?

This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2019-04-01. Estimated completion is 2021-02-01.

What conditions does trial NCT04072159 study?

This clinical trial studies the following conditions: Human Papillomavirus Vaccines.

What interventions are being tested in trial NCT04072159?

The interventions under investigation include: Community Pharmacists Vaccinating Against Cancer (BEHAVIORAL).

Who is sponsoring clinical trial NCT04072159?

This trial is sponsored by Arizona State University, which has 187 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04072159 being conducted?

This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.